| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0009-8981(82)90145-0 |
| P698 | PubMed publication ID | 7105424 |
| P2093 | author name string | Tiselius HG | |
| P433 | issue | 3 | |
| P921 | main subject | patient | Q181600 |
| calcium oxalate | Q412399 | ||
| P304 | page(s) | 409-418 | |
| P577 | publication date | 1982-07-01 | |
| P1433 | published in | Clinica Chimica Acta | Q5133740 |
| P1476 | title | An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. | |
| P478 | volume | 122 |
| Q86414436 | A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time |
| Q44632460 | An approximate estimate of the ion-activity product of calcium oxalate in rat urine |
| Q46908292 | Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria. |
| Q41081025 | Calcium phosphate: an important crystal phase in patients with recurrent calcium stone formation? |
| Q45223776 | Can a relationship reflect the risk of calcium oxalate urolithiasis? |
| Q67967000 | Crystal growth of calcium oxalate in urine of stone-formers and normal controls |
| Q54419864 | Crystallization Properties in Urine from Calcium Oxalate Stone Formers |
| Q38721692 | Different effects of γ-linolenic acid (GLA) supplementation on plasma and red blood cell phospholipid fatty acid composition and calcium oxalate kidney stone risk factors in healthy subjects from two race groups with different risk profiles pose que |
| Q41006117 | Do teas rich in antioxidants reduce the physicochemical and peroxidative risk factors for calcium oxalate nephrolithiasis in humans? Pilot studies with Rooibos herbal tea and Japanese green tea. |
| Q44499089 | Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy |
| Q72887949 | Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers |
| Q68733886 | Effects of different doses of alkaline citrate on urine composition and crystallization of calcium oxalate |
| Q73326742 | Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule |
| Q40710963 | Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist? |
| Q43638730 | Folium pyrrosiae ingestion has no effect on the thermodynamic or kinetic urinary risk factors for calcium oxalate urolithiasis in healthy subjects: a poor prognosis for alternative treatment in this type of stone former |
| Q36699784 | Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats |
| Q34114598 | Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders. |
| Q67967002 | Inhibition of calcium oxalate crystallization by urinary macromolecules |
| Q44080232 | Intestinal absorption of oxalate and calcium in patients with jejunoileal bypass |
| Q57113492 | Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles |
| Q70176536 | Juvenile Renal Stone Disease: A Study of Urinary Promoting and Inhibiting Factors |
| Q51734597 | Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region. |
| Q51576559 | Lack of increased urinary calcium-oxalate supersaturation in long-term kidney transplant recipients. |
| Q54401994 | Measurement of the risk of calcium oxalate crystallization in urine. |
| Q35021726 | Medical evaluation of nephrolithiasis |
| Q46800533 | Oxalate and its handling in a low stone risk vs a stone-prone population group |
| Q33568884 | Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet |
| Q46471961 | Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial |
| Q54346661 | Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. |
| Q43993176 | Risk factors for developing renal stones in inflammatory bowel disease |
| Q40912345 | Risk formulas in calcium oxalate urolithiasis |
| Q33897737 | Role of diet in the therapy of urolithiasis |
| Q51463857 | Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine. |
| Q45936096 | Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats. |
| Q70794088 | Studies on crystalluria in calcium oxalate stone formers |
| Q89357348 | Testing the dogma that total phospholipid fatty acid composition of blood plays a role in kidney stone pathogenesis, using a high-low risk human model: results from a pilot study |
| Q54615407 | The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation. |
| Q43543914 | The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects |
| Q69373954 | Treatment of enteric hyperoxaluria with calcium-containing organic marine hydrocolloid |
| Q45351730 | Urinary lithogenesis risk tests: comparison of a commercial kit and a laboratory prototype test. |
| Q73146517 | Urinary supersaturation of calcium oxalate and phosphate in patients with X-linked hypophosphatemic rickets and in healthy schoolchildren |
| Q42215438 | Urine composition and stone formation during treatment with acetazolamide |
Search more.